Effect of interferon α and cell cycle progression on translation mediated by the hepatitis C virus 5′ untranslated region: A study using a transgenic mouse model

Journal of Viral Hepatitis

Volumn 11, Issue 1, 2004, Pages 33-44

  Takeda, Y ^a   Okoshi, S ^a,b   Suzuki, K ^a   Yano, M ^a   Gangemi, J D ^c   Jay, G ^b   Asakura, H ^a   Aoyagi, Y ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b ORI Inc   (United States)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

5 UTR; HCV; Hepatocellular carcinoma; IFN ; Transgenic mouse

Indexed keywords

ALBUMIN; ALPHA INTERFERON; ANTIVIRUS AGENT; LIVER EXTRACT;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE EXPRESSION; HEPATITIS C; IN VIVO STUDY; LIVER CELL; LIVER RESECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; TRANSGENE; TRANSGENIC MOUSE; TRANSLATION INITIATION; VIRUS HEPATITIS;

5' UNTRANSLATED REGIONS; ANIMALS; ANTIVIRAL AGENTS; BETA-GALACTOSIDASE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, REPORTER; HEPACIVIRUS; HEPATOCYTES; INTERFERON TYPE I, RECOMBINANT; LAC OPERON; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; RNA, VIRAL; SERUM ALBUMIN; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 1242337441     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00472.x     Document Type: Article

References (43)

1. Houghton M. Hepatitis C viruses. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin RA, Roizman B, Straus SE, Knipe DM, eds. Fields Virology. 3rd edn. Philadelphia: Lippincott-Raven, 1996: 1035-1058.
2. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26(Suppl. 1): 34S-38S.
3. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
4. Vaquer P, Canet R, Llompart A, Riera J, Obrador A, Gaya J. Histological evolution of chronic hepatitis C. Factors related to progression. Liver 1994; 14: 265-269.
5. Ikeda K, Saitoh S, Arase Y et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999; 29: 1124-1130.
6. Takimoto M, Ohkoshi S, Ichida T et al. Interferon inhibits the progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in the patients with chronic hepatitis C - a retrospective multi-center analysis of 652 patients. Dig Dis Sci 2002; 47: 170-176.
7. Kato N, Hijikata M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524-9528.
8. Choo Q-L, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455.
9. Grakoui A, McCourt DW, Wychowski CS, Feinstone M, Rice CM. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 1993; 67: 2832-2843.
10. Selby MJ, Choo Q-L, Berger K et al. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993; 74: 1103-1113.
11. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ non-coding region of hepatitis C virus. Proc Natl Acad Sci USA 1992; 89: 4942-4946.
12. Brown EA, Zhang H, Ping L-H, Lemon SM. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992; 20: 5041-5045.
13. Honda M, Beard MR, Ping L-H, Lemon S. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 1999; 73: 1165-1174.
14. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66: 1476-1483.
15. Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 1993; 67: 3338-3344.
16. Rijnbrand R, Bredenbeek P, van der Staaten T et al. Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett 1995; 365: 115-119.
17. Reynolds JE, Kaminski A, Kettinen HJ et al. Unique features of internal initiation of hepatitis C virus translation. EMBO J 1995; 14: 6010-6020.
18. Kamoshita N, Tsukiyama-Kohara K, Kohara M, Nomoto A. Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology 1997; 233: 9-18.
19. Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 1998; 12: 67-83.
20. Ali N, Siddiqui A. Interraction of polypyrimidine tract-binding protein with the 5′ non-coding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J Virol 1995; 69: 6367-6375.
21. Isoyama T, Kamoshita N, Yasui K et al. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J Gen Virol 1999; 80: 2319-2327.
22. Kato N, Nakazawa T, Mizutani T, Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun 1995; 206: 863-869.
23. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 1992; 89: 5477-5481.
24. Yoo BJ, Selby MJ, Choe J et al. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol 1995; 69: 32-38.
25. Okoshi S, Takeda Y, Takimoto M, Shimotohno K, Asakura H, Jay G. Molecular dissection of hepatitis C virus expression. Intervirology 2001; 44: 21-28.
26. Pinkert CA, Ornitz DM, Brinster RL, Palmitter RD. An albumin enhancer located 10 kb upstream functions along its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev 1987; 1: 268-276.
27. Sanderson N, Factor V, Nagy P et al. Hepatic expression of mature transforming growth factor β 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92: 2572-2576.
28. Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 1986; 47: 767-776.
29. Kim CM, Koike K, Saito M, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320.
30. Horisberger MA, Staritzky, KD. A recombinant human interferon-αB/D hybrid with a broad host range. J Gen Virol 1987; 68: 945-948.
31. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
32. Higgins GM, Anderson RM. Experimental pathology of the liver: the restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12; 186-202.
33. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263: 1149-1152.
34. IhIe JN, Witthuhn BA, Qualle FW et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994; 19: 222-227.
35. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000; 118: 152-162.
36. Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 2001; 75: 1252-1264.
37. Kettinen H, Grace K, Grunert S, Clarke B, Rowlands D, Jackson R. Mapping of the internal ribosome entry site at the 5′ end of the hepatitis C virus genome. Viral Hepat Liver Dis 1994: 125-131.
38. Massimi M, Lear SR, Williams DL, Jones AL, Erickson SK. Differential expression of apolipoprotein E messenger RNA within the rat liver lobule determined by in situ hybridization. Hepatology 1999; 29: 1549-1555.
39. Bonneau A-M, Sonenberg N. Involvement of the 24-kDa cap-binding protein in regulation of proten synthesis in mitosis. J Biol Chem 1987; 262: 11134-11139.
40. Huang J, Schneider RJ. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell 1991; 65: 271-280.
41. Hamada M, Kihara T, Takase K, Nakano T, Tameda Y, Kosaka Y. Hepatocyte regeneration in chronic hepatitis C and interferon treatment: analysis of immunohistological identification of proliferating cell nuclear antigen (PCNA). J Gastroenterol 1995; 30: 372-378.
42. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26(Suppl. 1): 57S-61S.
43. Gordon SC, Dailey PJ, Silverman AL, Khan BA, Kodall VP, Wilber JC. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification. RNA translation. Hepatology 1998; 28: 1702-1707.